Frontiers in Basic Cancer Research 2011: Interview with James P. Allison, Ph.D., director, Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center
Dr. Allison talks about his work at the forefront of immunotherapeutics and the development of ipilimumab, the first immunotherapy to show improved survival in patients with melanoma.
* the mp4 of the video (346.6 MB; Time: 15:52)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.
Updated: Sept. 15, 2011